CURIS, INC. Proceeds from Divestiture of Interest in Consolidated Subsidiaries
CURIS, INC. (CRIS) reported Proceeds from Divestiture of Interest in Consolidated Subsidiaries of $2.50 million for the 1-month period ending 2025-11-30, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries · last filed 2026-03-24
- 2025-11-30: Proceeds from Divestiture of Interest in Consolidated Subsidiaries 1 month $2.50M.
| Period end | Proceeds from Divestiture of Interest in Consolidated Subsidiaries 1 month |
|---|---|
| 2025-11-30 | $2.50M 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |